Cargando…

Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas

Our previous reports demonstrated that NAC1, a BTB/POZ domain-containing nuclear protein, upregulates in recurrent ovarian serous carcinoma and participates in developing drug resistance in cancer cells. The current study applies quantitative proteomics to identify the proteins controlled by NAC1 by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Stefanie M., Yap, Kai Lee, Davidson, Ben, Tian, Yuan, Murthy, Vivek, Wang, Tian-Li, Visvanathan, Kala, Kuhajda, Francis P., Bristow, Robert E., Zhang, Hui, Shih, Ie-Ming
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873657/ https://www.ncbi.nlm.nih.gov/pubmed/20508725 http://dx.doi.org/10.1155/2010/285191

Ejemplares similares

Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
por: Gross, Amy L., et al.
Publicado: (2010)

Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase
por: Sehdev, Ann Smith, et al.
Publicado: (2010)

Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
por: Davidson, Ben, et al.
Publicado: (2011)

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway
por: Jinawath, Natini, et al.
Publicado: (2009)

Multiomic characterization of high-grade serous ovarian carcinoma: editorial commentary on recent application and consideration for future directions
por: Jones, Tiffany Nicole, et al.
Publicado: (2023)

BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2019)

Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2021)

Amplification of The ch19p13.2 NACC1 Locus in Ovarian High-grade Serous Carcinoma
por: Shih, Ie-Ming, et al.
Publicado: (2011)

Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas
por: Rahman, M T, et al.
Publicado: (2012)

Hyaluronan Synthase and Hyaluronidase Expression in Serous Ovarian Carcinoma is Related to Anatomic Site and Chemotherapy Exposure
por: Weiss, Ilana, et al.
Publicado: (2012)

NAC1 Modulates Sensitivity of Ovarian Cancer Cells to Cisplatin via Altering the HMGB1-Mediated Autophagic Response
por: Zhang, Yi, et al.
Publicado: (2011)

CCNE1 Amplification and Centrosome Number Abnormality in Serous Tubal Intraepithelial Carcinoma- Further Evidence Supporting its Role as a Precursor of Ovarian High-Grade Serous Carcinoma
por: Kuhn, Elisabetta, et al.
Publicado: (2016)

DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression
por: Kshirsagar, Malti, et al.
Publicado: (2012)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

Loss of NAC1 Expression Is Associated with Defective Bony Patterning in the Murine Vertebral Axis
por: Yap, Kai Lee, et al.
Publicado: (2013)

High grade serous ovarian carcinomas originate in the fallopian tube
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2017)

Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma
por: Serna-Gallegos, Tasha, et al.
Publicado: (2016)

Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
por: Cai, Yunlang, et al.
Publicado: (2014)

The Role of Forkhead Box Q1 Transcription Factor in Ovarian Epithelial Carcinomas
por: Gao, Min, et al.
Publicado: (2012)

Isolated recurrence of ovarian serous adenocarcinoma to adrenal gland
por: Borczuk, Rachel, et al.
Publicado: (2022)

Evaluation of the expression of fatty acid synthase and O-GlcNAc transferase in patients with liver cancer by exploration of transcriptome databases and experimental approaches
por: Raab, Sadia, et al.
Publicado: (2022)

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells
por: Gao, Min, et al.
Publicado: (2020)

Low-grade serous ovarian cancer: expert consensus report on the state of the science
por: Grisham, Rachel N, et al.
Publicado: (2023)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

Low-Grade Ovarian Serous Adenocarcinoma with Lymph Node Metastasis in Neck
por: Chen, Shih-Lung, et al.
Publicado: (2021)

Outcome in serous ovarian cancer is not associated with LATS expression
por: Montavon, Céline, et al.
Publicado: (2019)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
por: Jinawath, Natini, et al.
Publicado: (2010)

Involvement of DPP9 in gene fusions in serous ovarian carcinoma
por: Smebye, Marianne Lislerud, et al.
Publicado: (2017)

Ovarian Carcinoma and Serous Effusions. Changing Views Regarding Tumor Progression and Review of Current Literature
por: Davidson, Ben
Publicado: (2001)

Antihypertensive Drug Use and the Risk of Ovarian Cancer Death among Finnish Ovarian Cancer Patients—A Nationwide Cohort Study
por: Santala, Eerik E. E., et al.
Publicado: (2021)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
por: Bauerschlag, Dirk O, et al.
Publicado: (2015)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase
por: Liang, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dqhipjedht0g04vudq2k7tborr